AChE/PDE5A dual inhibitors (Central South University)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameAChE/PDE5A dual inhibitors (Central South University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsPhosphodiesterase 5A inhibitors
TargetsAcetylcholinesterasePhosphodiesterase 5A
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesCentral South University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentral South University
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A